Chylothorax
Conditions
Interventions
After orally administeration of radioactive pharmaceuticals, I-123 BMIPP, drug dynamics is tracked with a gamma camera.
Sponsors
Tohoku University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Currently not visiting a hospital (2)No history of chest and abdominal surgery (3)Male and female aged 20 years and over when acquiring consent (4)Accept written oral and written explanation about participation in research and agree on written agreement
Exclusion criteria
Exclusion criteria: (1)Difficulty fasting from the night inspection the day before (2)Allergic to iodine or milk (3)Severe back pain (4)Possible pregnancy, during pregnancy, within 28 days after birth, or nursing (5)Aspiration, impaired passage of gastrointestinal tract (6)Difficult to climb up and down stairs (7)Mental psychosis or psychiatric symptoms (8)Judging undesirable as the subject of this study by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of the time the drug passes through the stomach after administration of radiopharmaceutical, the time until the thoracic duct is depicted, and the time until the systemic circulation is visualized. | — |
Countries
Japan
Contacts
Public ContactKentaro Takanami
Tohoku University Hospital Department of Diagnostic Radiology
Outcome results
None listed